Anemia

ASH: Gene therapy reduces transfusion needs in beta-thalassemia major

Publish date: December 5, 2015

Lentiviral-based gene therapy can lead to transfusion independence in some patients with beta-thalassemia major.

Publish date: October 14, 2015

The body’s microbiota was found to regulate the aging of circulating neutrophils, a discovery that points the way to easily and markedly improve...

Publish date: April 28, 2015

Key clinical point: More than 75% of adults with sickle cell anemia who have frequent pain crises fail to get hydroxyurea therapy as recommended....

Publish date: March 16, 2015

Publish date: September 9, 2014

Major finding: The two most widely available disease-modifying therapies for SCD, hydroxyurea and long-term transfusions, are underused, in large...

Publish date: December 10, 2013

Major finding: The mean time to resolution of vaso-occlusive crisis in patients with sickle cell disease was 103 hours for patients treated with...

Publish date: October 14, 2011